2024
Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report
Paraskevas K, Dardik A, Schermerhorn M, Liapis C, Mansilha A, Lal B, Gray W, Brown M, Myrcha P, Lavie C, Zeebregts C, Secemsky E, Saba L, Blecha M, Gurevich V, Silvestrini M, Blinc A, Svetlikov A, Fernandes e Fernandes J, Schneider P, Gloviczki P, White C, AbuRahma A. Why selective screening for asymptomatic carotid stenosis is currently appropriate: a special report. Expert Review Of Cardiovascular Therapy 2024, 22: 159-165. PMID: 38480465, DOI: 10.1080/14779072.2024.2330660.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsScreening programMass screening programPopulation-wide screening programsRisk factor modificationHigh riskHigh risk of strokeMyocardial infarctionInitiation of preventive measuresRisk of strokeIntensive medical therapyAsymptomatic carotid artery stenosisFactor modificationCost-effectiveLifestyle measuresPrevent future strokeAsymptomatic carotid stenosisTargeted screeningCarotid artery stenosisFuture strokeScreening of populationsCarotid revascularization proceduresProphylactic carotid interventionMedical therapyPreventive measuresCV events
2023
Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys
Ebrahimi H, Masinaei M, Aminorroaya A, Aryan Z, Mehdipour P, Rostam-Abadi Y, Ahmadi N, Moghaddam S, Pishgar F, Ghanbari A, Rezaei N, Takian A, Farzadfar F. Risk of incident cardiovascular diseases at national and subnational levels in Iran from 2000 to 2016 and projection through 2030: Insights from Iran STEPS surveys. PLOS ONE 2023, 18: e0290006. PMID: 37611004, PMCID: PMC10446220, DOI: 10.1371/journal.pone.0290006.Peer-Reviewed Original ResearchConceptsCardiovascular disease riskRisk of cardiovascular diseaseNon-communicable disease risk factor surveillanceCardiovascular diseaseCVD riskWorld Health OrganizationRisk of incident cardiovascular diseaseRisk factor surveillanceFramingham 10-year CVD riskAdult Iranian populationIncident cardiovascular diseaseRisk factor modificationCardiovascular disease risk stratificationEvidence-based decisionsFramingham modelHealth policyNationally representative datasetFactor modificationRisk estimation modelIranian populationHealth OrganizationFraminghamSurvey's backgroundRiskSubnational level
2022
Clinical decision support in cardiovascular medicine
Lu Y, Melnick ER, Krumholz HM. Clinical decision support in cardiovascular medicine. The BMJ 2022, 377: e059818. PMID: 35613721, DOI: 10.1136/bmj-2020-059818.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseCardiovascular careEffectiveness of CDSRisk factor modificationClinical decision support toolQuality of careClinical decision supportClinical outcomesFactor modificationHealth information technologyClinical practicePatient careDiseaseCardiovascular medicineCDS effectivenessCareEffectiveness of deliveryMissed opportunityTreatmentFailureProper evidenceHealthcare processesMedicineEvidencePreventionAssociations of self-reported occupational exposures and settings to ALS: a case–control study
Goutman S, Boss J, Godwin C, Mukherjee B, Feldman E, Batterman S. Associations of self-reported occupational exposures and settings to ALS: a case–control study. International Archives Of Occupational And Environmental Health 2022, 95: 1567-1586. PMID: 35593931, PMCID: PMC9424174, DOI: 10.1007/s00420-022-01874-4.Peer-Reviewed Original ResearchConceptsStandard Occupational ClassificationStandard Occupational Classification codesExposure to particulate matterProductive occupationsALS riskSelf-reported occupational exposureHigher risk of amyotrophic lateral sclerosisOccupational exposureHigher ALS riskRisk of amyotrophic lateral sclerosisRisk factor modificationOccupational exposure to particulate matterExposure surveyIncreased ALS riskCase-control studyMaintenance occupationsGrounds cleaningFactor modificationExposure scoreTargeted screeningAmyotrophic lateral sclerosis diagnosisRepair occupationsAdaptive elastic net modelOccupational classificationProgressive neurological disease
2020
Opportunities for improved cardiovascular disease prevention in oncology patients.
Bravo-Jaimes K, Marcellon R, Varanitskaya L, Kim PY, Iliescu C, Gilchrist SC, Baldassarre LA, Manisty C, Ghosh AK, Guha A, Lopez-Mattei JC. Opportunities for improved cardiovascular disease prevention in oncology patients. Current Opinion In Cardiology 2020, 35: 531-537. PMID: 32649353, DOI: 10.1097/hco.0000000000000767.Peer-Reviewed Original ResearchConceptsCardiovascular disease preventionCancer patientsDisease preventionCardiovascular disease prevention guidelinesCardiac risk factor modificationCancer treatmentCardiometabolic disease managementDisease prevention guidelinesCardiovascular risk factorsHigh cardiovascular riskRisk factor modificationAdverse cardiovascular outcomesRisk of cardiotoxicityOngoing clinical trialsNonpharmacologic therapiesCardiovascular eventsCardiovascular outcomesCardiovascular riskOncology patientsCancer survivorsPrevention guidelinesAdverse outcomesFactor modificationCardiorespiratory fitnessRisk factors
2019
Interventions to Reduce Ethnic and Racial Disparities in Dyslipidemia Management
Chang A, Abou-Arraj N, Rodriguez F. Interventions to Reduce Ethnic and Racial Disparities in Dyslipidemia Management. Current Treatment Options In Cardiovascular Medicine 2019, 21: 24. PMID: 31065884, DOI: 10.1007/s11936-019-0725-4.Peer-Reviewed Original ResearchPhase of careAssociated with disparitiesRisk factor modificationControl of dyslipidemiaEthnic minority groupsMultidisciplinary treatment teamImproving clinical endpointsRacial/ethnic disparitiesScreening practicesDyslipidemia diagnosisTreatment cascadeRacial disparitiesPatient awarenessFactor modificationTreatment teamTargeted risk assessmentReduce inequalitiesMinority groupsNative American populationsDisparitiesInterventionCardiovascular riskAmerican populationCareCardiovascular outcomes
2014
Management of Atherosclerotic Aortoiliac Occlusive Disease
Bujak M, Gamberdella J, Mena C. Management of Atherosclerotic Aortoiliac Occlusive Disease. Interventional Cardiology Clinics 2014, 3: 531-543. PMID: 28582078, DOI: 10.1016/j.iccl.2014.06.001.Peer-Reviewed Original ResearchAortoiliac occlusive diseaseOcclusive diseaseAtherosclerotic aortoiliac occlusive diseaseNew revascularization techniquesRisk factor modificationClassic risk factorsGold standard therapyInvasive endovascular techniquesCardiovascular eventsRevascularization techniquesStandard therapyAtherosclerotic diseaseEndovascular techniquesSmoking cessationSurgical interventionSymptom improvementFactor modificationRisk factorsDiseaseTherapyPreventionSecondary goalHypertensionHyperlipidemiaSmokingPreclinical Left Ventricular Diastolic Dysfunction in Metabolic Syndrome
Ayalon N, Gopal DM, Mooney DM, Simonetti JS, Grossman JR, Dwivedi A, Donohue C, Perez AJ, Downing J, Gokce N, Miller EJ, Liang CS, Apovian CM, Colucci WS, Ho JE. Preclinical Left Ventricular Diastolic Dysfunction in Metabolic Syndrome. The American Journal Of Cardiology 2014, 114: 838-842. PMID: 25084691, PMCID: PMC4162746, DOI: 10.1016/j.amjcard.2014.06.013.Peer-Reviewed Original ResearchConceptsHigher LA diameterLV diastolic dysfunctionVentricular diastolic dysfunctionDiastolic dysfunctionMetabolic syndromeLV massLA diameterLV hypertrophyYounger ageEarly risk factor modificationHigher left atrial diameterLeft ventricular diastolic dysfunctionAntihypertensive medication useLeft atrial diameterRisk factor modificationGender-adjusted analysesHigher LV massBody mass indexTissue Doppler imagingAtrial diameterDiastolic functionBlood pressureMedication useMass indexFactor modification
2013
The association of tobacco use and gender to cardiac rehabilitation outcomes: a preliminary investigation
Weinberger AH, Mazure CM, McKee SA, Caulin-Glaser T. The association of tobacco use and gender to cardiac rehabilitation outcomes: a preliminary investigation. Journal Of Substance Use 2013, 19: 171-175. PMID: 24817825, PMCID: PMC4011657, DOI: 10.3109/14659891.2013.765515.Peer-Reviewed Original ResearchCardiac rehabilitation outcomesFormer tobacco usersTobacco useRisk factorsTobacco usersRehabilitation outcomesCardiovascular disease risk factor reductionCR entryCardiovascular risk factor modificationKey cardiovascular risk factorsComprehensive CR programRisk factor modificationRisk factor reductionCardiovascular risk factorsCVD risk factorsMaximal exercise capacityNon-HDL cholesterolRetrospective cohort analysisTarget goalsExercise capacityPrimary outcomeTotal cholesterolCardiac statusCR programFactor modification
2005
Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors
Page C, Rubin LE, Gusberg RJ, Dardik A. Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors. Journal Of Vascular Surgery 2005, 42: 1014-1018. PMID: 16275464, DOI: 10.1016/j.jvs.2005.06.019.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAcute DiseaseAngiographyFactor VFactor V DeficiencyFibrinolytic AgentsFollow-Up StudiesHeparinHeterozygoteHumansHyperhomocysteinemiaInjections, Intra-ArterialMaleMiddle AgedMutationPeripheral Vascular DiseasesPopliteal ArteryThromboembolismThrombolytic TherapyTissue Plasminogen ActivatorConceptsPeripheral arterial diseaseArterial diseaseArterial thrombosisPre-existing peripheral arterial diseaseAcute popliteal artery thrombosisAcute arterial thrombosisPopliteal artery thrombosisIntra-arterial thrombolysisRisk factor modificationDeep venous thrombosisLong-term treatmentFactor V LeidenArtery thrombosisAcute thrombosisVenous thrombosisHomocysteine levelsFactor modificationV LeidenNormal limitsThrombosisHyperhomocysteinemiaFolic acidDiseaseDisordersAnticoagulation
2004
Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age
Lansky AJ, Mehran R, Dangas G, Cristea E, Shirai K, Costa R, Costantini C, Tsuchiya Y, Carlier S, Mintz G, Cottin Y, Stone G, Moses J, Leon MB. Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. The American Journal Of Cardiology 2004, 93: 916-919. PMID: 15050498, DOI: 10.1016/j.amjcard.2003.12.046.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionYears of ageCoronary interventionVascular complicationsMyocardial infarctionMortality rateAggressive risk factor modificationQ-wave myocardial infarctionHospital vascular complicationsMore diabetes mellitusPredominance of diabetesNonfatal myocardial infarctionRisk factor modificationPremature coronary diseaseRisk factor profileOnly independent predictorMultivariable regression analysisLess hyperlipidemiaIschemic complicationsConsecutive patientsCoronary diseaseDiabetes mellitusIndependent predictorsPremature atherosclerosisFactor modification
2003
Patterns of Secondary Prevention in Older Patients Undergoing Coronary Artery Bypass Grafting During Hospitalization for Acute Myocardial Infarction
Foody JM, Ferdinand FD, Galusha D, Rathore SS, Masoudi FA, Havranek EP, Nilasena D, Radford MJ, Krumholz HM. Patterns of Secondary Prevention in Older Patients Undergoing Coronary Artery Bypass Grafting During Hospitalization for Acute Myocardial Infarction. Circulation 2003, 108: 24ii--28. PMID: 12970203, DOI: 10.1161/01.cir.0000087654.26917.00.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionCoronary artery bypassOlder patientsArtery bypassSecondary preventionMyocardial infarctionAggressive risk factor modificationUtilization of therapyRisk factor modificationLong-term mortalityYears of ageCABG patientsDischarge aspirinDischarge therapyEligible patientsCardiovascular eventsSurgical mortalityLipid loweringACE inhibitorsFactor modificationMedical recordsCABGPatientsEnzyme inhibitorsDisease severity
2001
Do Existing Databases Answer Clinical Questions about Geriatric Cardiovascular Disease and Stroke?
Cheitlin MD, Gerstenblith G, Hazzard WR, Pasternak R, Fried LP, Rich MW, Krumholz HM, Peterson E, Reves JG, McKay C, Saksena S, Shen WK, Akhtar M, Brass LM, Biller J. Do Existing Databases Answer Clinical Questions about Geriatric Cardiovascular Disease and Stroke? The American Journal Of Geriatric Cardiology 2001, 10: 207-223. PMID: 11455241, DOI: 10.1111/j.1076-7460.2003.00696.x.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseYounger patientsChronic coronary artery diseaseExtrapolation of safetyRole of revascularizationChronic heart failurePatients 75 yearsRisk factor modificationCharacteristics of patientsCoronary artery diseaseAcute myocardial infarctionYears of ageCollaborative outcomes researchPrincipal investigatorGeriatric cardiologyValve surgeryArtery diseaseHeart failureCarotid endarterectomyFactor modificationMyocardial infarctionEfficacy dataCardiovascular conditionsClinical questionsAvailable safety
1997
A Review of Hereditary Breast Cancer: From Screening to Risk Factor Modification
Warmuth M, Sutton L, Winer E. A Review of Hereditary Breast Cancer: From Screening to Risk Factor Modification. The American Journal Of Medicine 1997, 102: 407-415. PMID: 9217624, DOI: 10.1016/s0002-9343(97)00093-4.Peer-Reviewed Original ResearchConceptsRisk factor modificationBreast cancerFactor modificationGenetic testingBreast cancer riskBreast cancer casesHereditary breast cancerPotential prophylactic measuresClinical managementBRCA2 mutationsCancer casesCancer riskProphylactic measuresWay patientsCancerGene mutationsGenetic mutationsGenetic testsGenetic aspectsMajor advancesBRCA1MutationsScreeningPatientsDisease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply